P189 The effect of COVID-19 and immunosuppressive drugs and diabetes on the spread of mucomycosis

Abstract

Abstract Poster session 2, September 22, 2022, 12:30 PM - 1:30 PM Mucormycosis is a serious but rare opportunistic fungal infection that spreads rapidly, so prompt diagnosis and treatment are essential to prevent high mortality rates and complications. Mucormycosis is caused by the inhalation of filamentous fungi, especially in patients with suppressed immune systems. Mucormycosis affected human populations after COVID-19. According to searches, invasive mucormycosis to COVID-19 has been widely reported from survivors, mild to severe. Of course, it seems that the underlying diseases and most importantly uncontrolled diabetes or immunosuppressive diseases have provided the conditions for the development of black fungus. In addition, over-the-counter administration of steroid drugs to control inflammation of the cornea seems to be another cause of the spread of the disease. Groups of patients were analyzed for the link between the COVID-19 epidemic and the nightmare of mucormycosis. Black fungus usually causes necrosis of the head and neck, including the nose, paranasal sinuses, and facial bones, which can sometimes cause complications. Therefore, the present study emphasizes mucormycosis and its associated conditions, its mechanism in normal individuals with COVID-19, the effective factors and challenges to overcome this black mold infection.